News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

BioAlliance Pharma Reinforces Its Development Team with the Appointment of Louis Kayitalire, MD, as Head of Research and Development


6/18/2012 10:27:30 AM

PARIS--(BUSINESS WIRE)--Regulatory News: BioAlliance Pharma SA (Euronext Paris - BIO), a Company dedicated to orphan oncology products and specialty products, today announces the reinforcement of its development team with the appointment of Louis Kayitalire, MD, as Head of Research and Development.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES